Bristol-Myers Squibb (BMY) Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.59 | 52 Week High | $77.12 | |||
| Open | $59.59 | 52 Week Low | $49.03 | |||
| Day High | $59.59 | P/E | 38.69 | |||
| Day Low | $59.59 | EPS | $1.54 | |||
| Volume | 6,216 | |||||
